COMPANY
Prenosis
Funding and NIH signals
- NIH award NIH awarded $1.22M (SBIR Phase II 1R44HL180159-01A1, new, notice Aug 21, 2026). NIH RePORTER 1R44HL180159-01A1 (Aug 21, 2026)
Evidence (1 event)
- Aug 21, 2026 · NIH RePORTER 1R44HL180159-01A1
Organization: PRENOSIS, INC.; City/State: CHAMPAIGN, IL; Project number: 1R44HL180159-01A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-21; FY total cost (award amount): 1218102; Administering IC: National Heart Lung and Blood Institute; Project title: Derivation and Validation of the Heart Failure CardioScore: an AI Diagnostic for HeartFailure using Novel Biomarkers and Clinical Data; Organization type: Domestic For-Profits
- Aug 21, 2026 · NIH RePORTER 1R44HL180159-01A1
Timeline
- Trial start —: Observational, Non-interventional Biomarker and Endotyping Study source ↗
- Grant Government grant — SBIR: $1.22M (annual award, as published), announced Aug 21, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
- Trial start —: Performance and Impact of the Sepsis ImmunoScore source ↗
- Grant Government contract: $20M (total, as published), announced Sep 30, 2025. Agency: HHS/ASPR (BARDA). Source: government award database. source ↗
- Grant Government grant — SBIR: $700,000 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
Upcoming milestones
- 2027-12 (ESTIMATED) · · Performance and Impact of the Sepsis ImmunoScore · NCT07543497
- 2028-12 (ESTIMATED) · · Observational, Non-interventional Biomarker and Endotyping Study · NCT07675265
Funding
- Government grant — SBIR: $1.22M (annual award, as published), announced Aug 21, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
- Government contract: $20M (total, as published), announced Sep 30, 2025. Agency: HHS/ASPR (BARDA). Source: government award database. source ↗
- Government grant — SBIR: $700,000 (annual award, as published), announced Aug 21, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07675265 | Observational, Non-interventional Biomarker and Endotyping Study | Not listed | Recruiting | Sep 14, 2026 | 2028-12 (estimated) |
| NCT07543497 | Performance and Impact of the Sepsis ImmunoScore | Not listed | Not yet recruiting | 2026-04 | 2027-12 (estimated) |